Page last updated: 2024-08-21

levonorgestrel and Venous Thromboembolism

levonorgestrel has been researched along with Venous Thromboembolism in 39 studies

Research

Studies (39)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (2.56)	29.6817
2010's	30 (76.92)	24.3611
2020's	8 (20.51)	2.80

Authors

Authors	Studies
Bertoia, ML; Dhanda, S; Evans, A; Kaplan, S; Lass, A; Roy, D; Seeger, JD; Wang, FT; Zhou, L	1
Braitmaier, M; Haug, U; Princk, C; Schink, T	1
Cockrum, RH; Cohen, KS; Ham, SA; Snow, SG; Soo, J	1
Wunder, D	1
Chen, L; de Meritens, AB; Hershman, DL; Hou, JY; Khoury-Collado, F; Matsuo, K; Melamed, A; St Clair, CM; Suzuki, Y; Wright, JD	1
Braga, GC; Brito, MB; Ferriani, RA; Garcia, AA; Oliveira, LC; Pintão, MC; Vieira, CS	1
Samuelson Bannow, B	1
Del Savio, MC; Facchinetti, F; Grandi, G	1
Cagnacci, A	1
Coulombe, J; Filion, KB; Larivée, N; Suissa, S; Tagalakis, V	1
Davey, DA	1
Hugon-Rodin, J; Plu-Bureau, G; Sabbagh, E	1
Hugon-Rodin, J; Plu-Bureau, G; Raccah-Tebeka, B	1
Bistervels, IM; Hamulyák, EN; Middeldorp, S; Scheres, LJJ	1
Bird, ST; Brophy, JM; Delaney, JA; Etminan, M; Hartzema, AG	1
Gronier, H; Gronier-Gouvernel, H; Robin, G	1
Schreiber, CA; Sober, S	1
Chabbert-Buffet, N; Jamin, C; Lello, S; Lete, I; Lobo, P; Nappi, RE; Pintiaux, A	1
Kluin-Nelemans, HC; Knol, HM; Mäkelburg, AB; Meijer, K; Tichelaar, VI; van Vlijmen, EF; Veeger, NJ	1
Mueck, AO; Ruan, X	1
Dinger, J; Do Minh, T; Heinemann, K	1
Abenhaim, HA; Eberg, M; Eisenberg, MJ; Filion, KB; Joseph, L; Larivée, N; Suissa, S	1
Curtis, KM; Dragoman, MV; Gaffield, ME; Tepper, NK	1
Cremers, S; Eisenberger, A; Pike, MC; Rosing, J; Thomassen, S; Westhoff, CL	1
Hagberg, KW; Hernandez, RK; Jick, SS; Kaye, JA	1
Dinger, J; Shapiro, S	1
Blanco-Molina, A; Monreal, M	1
Rosing, J; Tchaikovski, SN	1
Assmann, A; Dinger, J; Minh, TD; Möhner, S	1
Hernandez, RK; Jick, SS; Parkin, L; Sharples, K	1
Hernandez, RK; Jick, SS	1
Shapiro, S	1
Mansour, D; Szarewski, A	1
Heinemann, K; Heinemann, LA	1
Lidegaard, Ø; Løkkegaard, E; Nielsen, LH; Skjeldestad, FE; Skovlund, CW	1
Reid, RL	1
Voelker, R	1
Patel, A; Schwarz, EB	1
Hussain, MA; Latif, SA; Nessa, A; Uddin, MM	1

Reviews

12 review(s) available for levonorgestrel and Venous Thromboembolism

Article	Year
Management of heavy menstrual bleeding on anticoagulation. Hematology. American Society of Hematology. Education Program, 2020, 12-04, Volume: 2020, Issue:1 Topics: Adult; Anticoagulants; Female; Humans; Levonorgestrel; Menorrhagia; Pyrazoles; Pyridones; Quality of Life; Rivaroxaban; Venous Thromboembolism	2020
The paradigm of norgestimate: a third-generation testosterone-derivative progestin with a peripheral anti-androgenic activity and the lowest risk of venous thromboembolism. Expert review of clinical pharmacology, 2021, Volume: 14, Issue:2 Topics: Animals; Contraceptive Agents, Hormonal; Female; Humans; Levonorgestrel; Norgestrel; Risk; Venous Thromboembolism	2021
Hormonal contraception: venous and arterial disease. The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2017, Volume: 22, Issue:3 Topics: Adult; Androstenes; Atherosclerosis; Contraceptives, Oral, Synthetic; Female; Humans; Levonorgestrel; Middle Aged; Risk Factors; Venous Thromboembolism	2017
Menopausal hormone therapy: a better and safer future. Climacteric : the journal of the International Menopause Society, 2018, Volume: 21, Issue:5 Topics: Administration, Cutaneous; Administration, Oral; Endometrial Hyperplasia; Estrogens; Female; Hormone Replacement Therapy; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menopause; Progesterone; Progestins; Venous Thromboembolism	2018
Sex matters: Practice 5P's when treating young women with venous thromboembolism. Journal of thrombosis and haemostasis : JTH, 2019, Volume: 17, Issue:9 Topics: Adult; Anticoagulants; Contraceptives, Oral, Combined; Disease Susceptibility; Female; Heparin, Low-Molecular-Weight; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation; Metrorrhagia; Pregnancy; Pregnancy Complications, Hematologic; Puerperal Disorders; Recurrence; Risk Factors; Sex Factors; Stockings, Compression; Thrombophilia; Thrombophlebitis; Tranexamic Acid; Travel; Uterine Hemorrhage; Venous Thromboembolism; Young Adult	2019
Postpartum contraception. Clinical obstetrics and gynecology, 2014, Volume: 57, Issue:4 Topics: Amenorrhea; Birth Intervals; Breast Feeding; Condoms; Contraception; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Hormonal; Desogestrel; Drug Implants; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Medroxyprogesterone Acetate; Postpartum Period; Sterilization, Tubal; Venous Thromboembolism	2014
Haemostatic and metabolic impact of estradiol pills and drospirenone-containing ethinylestradiol pills vs. levonorgestrel-containing ethinylestradiol pills: A literature review. The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2015, Volume: 20, Issue:5 Topics: Androstenes; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Drug Combinations; Drug Therapy, Combination; Estradiol; Estrogens; Ethinyl Estradiol; Female; Hemostasis; Humans; Levonorgestrel; Lipid Metabolism; Megestrol; Nandrolone; Venous Thromboembolism	2015
Oral contraception for women of middle age. Maturitas, 2015, Volume: 82, Issue:3 Topics: Asian People; Contraception; Contraceptives, Oral, Combined; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Perimenopause; Practice Guidelines as Topic; Progestins; Venous Thromboembolism; White People	2015
Nonoral combined hormonal contraceptives and thromboembolism: a systematic review. Contraception, 2017, Volume: 95, Issue:2 Topics: Administration, Cutaneous; Adolescent; Adult; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Estrogens; Female; Humans; Levonorgestrel; Norgestrel; Progestins; Risk Factors; Thromboembolism; Venous Thromboembolism; Young Adult	2017
Risk of venous thromboembolism among users of oral contraceptives: a review of two recently published studies. The journal of family planning and reproductive health care, 2010, Volume: 36, Issue:1 Topics: Bias; Confounding Factors, Epidemiologic; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Denmark; Desogestrel; Estrogens; Female; Humans; Levonorgestrel; Netherlands; Progesterone; Progestins; Risk Factors; Time Factors; Venous Thromboembolism	2010
Venous thromboembolism in women taking hormonal contraceptives. Expert review of cardiovascular therapy, 2010, Volume: 8, Issue:2 Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Estrogens; Female; Humans; Immobilization; Incidence; Levonorgestrel; Mass Screening; Pulmonary Embolism; Risk Assessment; Thrombophilia; Venous Thromboembolism	2010
Mechanisms of estrogen-induced venous thromboembolism. Thrombosis research, 2010, Volume: 126, Issue:1 Topics: Blood Coagulation Factors; Contraception; Contraceptive Agents; Contraceptives, Oral; Estrogens; Female; Hemostasis; Humans; Levonorgestrel; Risk; Risk Factors; Venous Thromboembolism; Venous Thrombosis	2010

Other Studies

27 other study(ies) available for levonorgestrel and Venous Thromboembolism

Article	Year
Long-term safety of extended levonorgestrel-containing oral contraceptives in the United States. Contraception, 2022, Volume: 105 Topics: Cohort Studies; Contraceptives, Oral, Combined; Female; Humans; Incidence; Levonorgestrel; Risk Factors; United States; Venous Thromboembolism	2022
Use of combined oral contraceptives and risk of venous thromboembolism in young women: a nested case-control analysis using German claims data. BJOG : an international journal of obstetrics and gynaecology, 2022, Volume: 129, Issue:13 Topics: Case-Control Studies; Chlormadinone Acetate; Contraceptives, Oral, Combined; Desogestrel; Female; Humans; Levonorgestrel; Risk Factors; Venous Thromboembolism	2022
Association of Progestogens and Venous Thromboembolism Among Women of Reproductive Age. Obstetrics and gynecology, 2022, 09-01, Volume: 140, Issue:3 Topics: Adult; Case-Control Studies; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Progesterone; Progestins; Venous Thromboembolism	2022
[The Thromboembolism Risk with Combined Hormonal Contraceptives: Current Status and Prescribing Practice]. Praxis, 2023, Volume: 112, Issue:4 Topics: Contraceptive Agents; Female; Humans; Levonorgestrel; Risk Factors; Thrombosis; Venous Thromboembolism	2023
Systemic Progestins and Progestin-Releasing Intrauterine Device Therapy for Premenopausal Patients With Endometrial Intraepithelial Neoplasia. Obstetrics and gynecology, 2023, 05-01, Volume: 141, Issue:5 Topics: Endometrial Hyperplasia; Female; Humans; Intrauterine Devices; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Progestins; Uterine Neoplasms; Venous Thromboembolism	2023
Effect of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers among women with thrombophilia or previous venous thromboembolism. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2020, Volume: 148, Issue:3 Topics: Adolescent; Adult; Brazil; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Prospective Studies; Risk Factors; Thrombophilia; Venous Thromboembolism; Young Adult	2020
Drospirenone-Containing Oral Contraceptive Pills and the Risk of Venous Thromboembolism: An Assessment of Risk in First-Time Users and Restarters. Drug safety, 2017, Volume: 40, Issue:7 Topics: Adolescent; Adult; Androstenes; Cohort Studies; Contraceptives, Oral, Combined; Drug Administration Schedule; Female; Humans; Levonorgestrel; Middle Aged; Proportional Hazards Models; Risk Factors; Venous Thromboembolism; Young Adult	2017
[Hormonal contraception and vascular risk: CNGOF Contraception Guidelines]. Gynecologie, obstetrique, fertilite & senologie, 2018, Volume: 46, Issue:12 Topics: Androstenes; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Desogestrel; Female; France; Humans; Levonorgestrel; Norpregnenes; Progestins; Risk Factors; Vascular Diseases; Venous Thromboembolism	2018
[Hormonal contraception and vascular risk]. La Revue du praticien, 2018, Volume: 68, Issue:4 Topics: Contraception; Contraceptives, Oral, Combined; Female; Humans; Levonorgestrel; Progestins; Risk Factors; Venous Thromboembolism	2018
Drospirenone and non-fatal venous thromboembolism: is there a risk difference by dosage of ethinyl-estradiol? Journal of thrombosis and haemostasis : JTH, 2013, Volume: 11, Issue:6 Topics: Adolescent; Adult; Androstenes; Cohort Studies; Contraceptives, Oral; Databases, Factual; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Proportional Hazards Models; Risk; Time Factors; United States; Venous Thromboembolism; Young Adult	2013
[Cardiovascular risks of combined oral contraceptives - beyond the French controversy]. Gynecologie, obstetrique & fertilite, 2014, Volume: 42, Issue:3 Topics: Cardiovascular Diseases; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estrogens; Female; France; Humans; Levonorgestrel; Progestins; Risk Factors; Venous Thromboembolism	2014
Clinical profile and recurrence rate in women with venous thromboembolism during combined hormonal contraceptive use: a prospective cohort study. British journal of haematology, 2016, Volume: 172, Issue:4 Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Female; Humans; Levonorgestrel; Middle Aged; Prospective Studies; Recurrence; Risk Factors; Venous Thromboembolism; Young Adult	2016
Impact of estrogen type on cardiovascular safety of combined oral contraceptives. Contraception, 2016, Volume: 94, Issue:4 Topics: Adult; Cardiovascular Diseases; Contraceptives, Oral, Combined; Estradiol; Europe; Female; Follow-Up Studies; Humans; Incidence; Levonorgestrel; Longitudinal Studies; Nandrolone; Patient Reported Outcome Measures; Proportional Hazards Models; Prospective Studies; Surveys and Questionnaires; United States; Venous Thromboembolism; Young Adult	2016
Drospirenone-containing combined oral contraceptives and the risk of arterial thrombosis: a population-based nested case-control study. BJOG : an international journal of obstetrics and gynaecology, 2017, Volume: 124, Issue:11 Topics: Adolescent; Adult; Androstenes; Case-Control Studies; Contraceptives, Oral, Combined; Drug Administration Schedule; Female; Humans; Levonorgestrel; Middle Aged; Risk Factors; United Kingdom; Venous Thromboembolism; Young Adult	2017
Endogenous thrombin potential changes during the first cycle of oral contraceptive use. Contraception, 2017, Volume: 95, Issue:5 Topics: Adult; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Protein C; Risk Factors; Thrombin; Venous Thromboembolism	2017
Postmarketing study of ORTHO EVRA and levonorgestrel oral contraceptives containing hormonal contraceptives with 30 mcg of ethinyl estradiol in relation to nonfatal venous thromboembolism. Contraception, 2010, Volume: 81, Issue:1 Topics: Adolescent; Adult; Case-Control Studies; Confidence Intervals; Contraceptives, Oral; Databases, Factual; Drug Combinations; Ethinyl Estradiol; Female; Humans; Incidence; Levonorgestrel; Norgestrel; Odds Ratio; Product Surveillance, Postmarketing; United States; Venous Thromboembolism	2010
Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study. The journal of family planning and reproductive health care, 2010, Volume: 36, Issue:3 Topics: Adolescent; Adult; Androstenes; Case-Control Studies; Contraceptives, Oral; Estrogens; Ethinyl Estradiol; Female; Germany; Humans; Levonorgestrel; Logistic Models; Middle Aged; Mineralocorticoid Receptor Antagonists; Nandrolone; Risk Factors; Venous Thromboembolism; Young Adult	2010
Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database. BMJ (Clinical research ed.), 2011, Apr-21, Volume: 342 Topics: Adolescent; Adult; Age Distribution; Androstenes; Case-Control Studies; Contraceptives, Oral; Contraceptives, Oral, Combined; Estrogens; Female; Humans; Levonorgestrel; Risk Factors; United Kingdom; Venous Thromboembolism; Young Adult	2011
Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data. BMJ (Clinical research ed.), 2011, Apr-21, Volume: 342 Topics: Adolescent; Adult; Age Distribution; Androstenes; Case-Control Studies; Contraceptives, Oral, Combined; Female; Humans; Levonorgestrel; Risk Factors; United States; Venous Thromboembolism; Young Adult	2011
Venous thromboembolism is egregiously underestimated. BMJ (Clinical research ed.), 2011, May-31, Volume: 342 Topics: Androstenes; Contraceptives, Oral, Combined; Female; Humans; Levonorgestrel; Venous Thromboembolism	2011
Study subject to unmeasured confounders and biases. BMJ (Clinical research ed.), 2011, May-31, Volume: 342 Topics: Androstenes; Contraceptives, Oral, Combined; Female; Humans; Levonorgestrel; Venous Thromboembolism	2011
Comparative risks of venous thromboembolism among users of oral contraceptives containing drospirenone and levonorgestrel. The journal of family planning and reproductive health care, 2011, Volume: 37, Issue:3 Topics: Androstenes; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Female; Humans; Levonorgestrel; Mineralocorticoid Receptor Antagonists; Risk Assessment; Venous Thromboembolism	2011
Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9. BMJ (Clinical research ed.), 2011, Oct-25, Volume: 343 Topics: Adolescent; Adult; Androstenes; Anticoagulants; Cohort Studies; Confounding Factors, Epidemiologic; Contraceptives, Oral; Denmark; Desogestrel; Dose-Response Relationship, Drug; Epidemiologic Methods; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Mineralocorticoid Receptor Antagonists; Norpregnenes; Pregnancy; Time Factors; Venous Thromboembolism; Young Adult	2011
Oral contraceptives and venous thromboembolism: pill scares and public health. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2011, Volume: 33, Issue:11 Topics: Aged; Androstenes; Case-Control Studies; Contraceptives, Oral, Combined; Fear; Female; Humans; Levonorgestrel; Middle Aged; Prospective Studies; Public Health; Retrospective Studies; Risk Factors; Venous Thromboembolism	2011
Risk of blood clots higher for oral contraceptives with certain progestins. JAMA, 2011, Nov-23, Volume: 306, Issue:20 Topics: Androstenes; Contraceptives, Oral; Cyproterone; Denmark; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norpregnenes; Progestins; Registries; Risk; Venous Thromboembolism	2011
Cancer and contraception. Release date May 2012. SFP Guideline #20121. Contraception, 2012, Volume: 86, Issue:3 Topics: Anemia; Antineoplastic Agents, Hormonal; Breast Neoplasms; Contraception; Contraceptive Agents, Female; Estrogens; Female; Humans; Immunosuppression Therapy; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Neoplasms; Osteoporosis; Progestins; Tamoxifen; Venous Thromboembolism	2012
Serum HDL-cholesterol in women using low dose oral contraceptives. Mymensingh medical journal : MMJ, 2007, Volume: 16, Issue:2 Suppl Topics: Adult; Age Factors; Cholesterol, HDL; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Myocardial Ischemia; Prospective Studies; Risk Factors; Venous Thromboembolism	2007